Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Derm-it Trotter! Don't Swear About Skincare.

Scratch That! Conquer Chronic Itch

05 Nov 2024

Description

Unlock the secrets to understanding and managing chronic itch in our latest episode, where we break down the complexities of this often misunderstood condition. Featuring insights from the esteemed Dr. Diego Ruiz Dasilva, this episode promises to enhance your knowledge on the spectrum of itch causes—ranging from run-of-the-mill irritants like poison ivy to intricate neuropathic itches. We draw a parallel between itch and pain, emphasizing how both can severely impact one's mental health and quality of life.Our conversation takes a deep dive into the tangled web of itch and anxiety, uncovering how these two often exacerbate each other. Dr. Diego Ruiz Dasilva sheds light on the societal embarrassment that comes with chronic itching, amplifying anxiety levels and complicating treatment. We also address the stigma around mental health medications, suggesting a fresh perspective on these drugs as tools for correcting nerve misfiring to help patients feel more comfortable with them. Plus, we discuss when you might need further lab work to get to the bottom of skin conditions linked with itch.Finally, we offer practical tips that you can incorporate into your daily skincare routine to manage itchiness and keep your skin happy. From eliminating potential irritants in your products to the importance of moisturizing with thicker creams, we cover it all. And, Dr. Diego Ruiz Dasilva provides an optimistic view on emerging treatments, providing hope for those plagued by chronic itch. Connect with us online for more insights, at dermittrotter.com.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.